期刊文献+

高危神经母细胞瘤的治疗 被引量:21

A review on treatment of high-risk neuroblastoma
原文传递
导出
摘要 高危神经母细胞瘤由于其恶性程度高,治疗十分困难,目前认为综合治疗仍是该病的主要治疗方法,包括大剂量联合化疗、手术切除、造血干细胞移植、放射治疗、生物治疗、免疫治疗及靶向治疗等。近年来免疫治疗取得了一定进展。该文介绍了一些高危神经母细胞瘤常用治疗方法,希望对该病的临床诊治有所帮助。 So far treatment of advanced neuroblastoma is still difficult, due to its high malignancy. Currently comprehensive therapies, including high-dose multi-drug chemotherapy, surgery, stem cell transplantation, radiation, biological therapy and immune therapy as well as target therapy dominant the treatment of this disease, and we hereby introduce the latest development of treatment protocols for this disease.
作者 唐锁勤
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2014年第2期103-107,共5页 Chinese Journal of Contemporary Pediatrics
关键词 神经母细胞瘤 化疗 免疫治疗 儿童 Neuroblastoma Chemotherapy, Immunotharapy Child
  • 相关文献

参考文献11

  • 1Mattano LA Jr,Moss TJ,Emerson SG. Sensitive detection of rare circulating neuroblastoma ceils by the reverse transcriptasepolymerase chain reaction[J].{H}CANCER RESEARCH,1992,(17):4701-4705.
  • 2Stram DO,Matthay KK,O'Leary M. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma:a report of two concurrent Children's Cancer Group studies[J].{H}Journal of Clinical Oncology,1996,(9):2417-2426.
  • 3Vogelzang N J,Benowitz SI,Adams S. Clinical cancer advances 2011:Annual Report on Progress Against Cancer from the American Society of Clinical Oncology[J].{H}Journal of Clinical Oncology,2012,(1):88-109.
  • 4Castel V,Tovar JA,Costa E. The role of surgery in stage Ⅳ neuroblastoma[J].{H}Journal of Pediatric Surgery,2002,(11):1574-1578.
  • 5Wilson JS,Gains JE,Moroz V. A systematic review of 1311-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma[J].{H}EUROPEAN JOURNAL OF CANCER,2013.
  • 6Kreissman SG,Seeger RC,Matthay KK. Purged versus non-purged peripheral blood stem-cell transplantation for highrisk neuroblastoma (COG A3973):a randomised phase 3 trial[J].{H}LANCET ONCOLOGY,2013,(10):999-1008.
  • 7Yu AL,Uttenreuther-Fischer MM,Huang CS. Phase Ⅰ trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma[J].{H}Journal of Clinical Oncology,1998,(6):2169-2180.
  • 8Handgretinger R,Anderson K,Lang P. A phase Ⅰ study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients withneuroblastoma[J].{H}EUROPEAN JOURNAL OF CANCER,1995,(2):261-267.
  • 9Yu AL,Gilman AL,Ozkaynak MF. Ami-GD2 antibody with GM-CSF,interleukin-2,and isotretinoin for neuroblastoma[J].{H}New England Journal of Medicine,2010,(14):1324-1334.
  • 10Morgenstern DA,Baruchel S,Irwin MS. Current and future strategies for relapsed neuroblastoma:challenges on the road to precision therapy[J].{H}Journal of Pediatric Hematology Oncology,2013,(5):337-347.

同被引文献156

引证文献21

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部